![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Open AccessElevated mRNA expression of CHAC1 splicing variants is associated with poor outcome for breast and ovarian cancer patients
The role of CHAC1 (cation transport regulator-like protein 1), a recently identified component of the unfolded protein response (UPR) pathway, in gynaecological cancers has not yet been characterised. Now, thi...
-
Article
Open AccessThe treatment of early breast cancer in women over the age of 70
One third of all breast cancers are diagnosed in women aged 70 or over. Older women are a heterogeneous population who are under-represented in clinical trials, and as a result uncertainty can exist as to what...
-
Article
Open AccessIdiopathic venous thromboembolic disease is associated with a poorer prognosis from subsequent malignancy
We carried out a retrospective study of prognosis in Scottish patients diagnosed with cancer within 5 years after a venous thromboembolism (VTE).
-
Article
Open AccessWaiting times for systemic cancer therapy in the United Kingdom in 2006
This audit was conducted to measure waiting times for systemic cancer therapy across the United Kingdom. All patients, aged 16 years or older, commencing their first course of systemic therapy between 13 Novem...
-
Article
Patient satisfaction with nurse-led telephone consultation for the follow-up of patients with prostate cancer
Prostate cancer is being diagnosed earlier and in higher numbers than ever before. The nature of the disease means many patients have to be monitored regularly and for a prolonged period leading to increased p...
-
Article
Open AccessMedical student teaching in the UK: how well are newly qualified doctors prepared for their role caring for patients with cancer in hospital?
A number of studies have identified problems with undergraduate oncology teaching. We have investigated how well prepared newly qualified doctors (first foundation year, or FY1 doctors) are for treating patien...
-
Article
Open AccessVinorelbine alternating oral and intravenous plus epirubicin in first-line therapy of metastatic breast cancer: results of a multicentre phase II study
The combination of intravenous (i.v.) vinorelbine and epirubicin is highly active in the treatment of metastatic breast cancer (MBC). In an effort to improve patient convenience, we investigated a regimen alte...
-
Article
Open AccessPhase I trial of intravesical Suramin in recurrent superficial transitional cell bladder carcinoma
Suramin is an antitrypanosomal agent with antineoplastic activity, but with serious systemic side effects. We administered Suramin intravesically to determine a concentration with low toxicity but with evidenc...
-
Article
Open AccessCooperative stimulation of vascular endothelial growth factor expression by hypoxia and reactive oxygen species: the effect of targeting vascular endothelial growth factor and oxidative stress in an orthotopic xenograft model of bladder carcinoma
Elevated thymidine phosphorylase has been shown to correlate with increased angiogenesis and poor prognosis in many cancers including transitional cell carcinoma of the bladder. In vitro studies have demonstrated...
-
Article
Open AccessTrends in postoperative radiotherapy delay and the effect on survival in breast cancer patients treated with conservation surgery
The adequate timing of adjuvant radiotherapy (RT) in breast cancer has become a subject of increasing interest in recent years. A population-based study was undertaken to determine the influence of demographic...
-
Article
Open AccessBlock sequential adriamycin CMF – optimal non-myeloablative chemotherapy for high risk adjuvant breast cancer?
After the publication of the 10-year survival data from Milan on the adjuvant use of the block sequential regimen consisting of four cycles of adriamycin followed by eight cycles of intravenous CMF, many centr...
-
Article
Open AccessHuman bladder cancer invasion model using rat bladder in vitro and its use to test mechanisms and therapeutic inhibitors of invasion
As well as being a passive support, the extracellular matrix also regulates key biological processes such as invasion, differentiation and angiogenesis. We have therefore developed an in vitro model of bladder...
-
Article
Technical approaches for efficient printing of high-density microarrays and rapid, high-precision fluorescence analysis
-
Article
A phase II study in advanced breast cancer: ZD1694 ('Tomudex') a novel direct and specific thymidylate synthase inhibitor
ZD1694 ('Tomudex'), a novel, direct and specific thymidylate synthase (TS) inhibitor, was developed in a collaborative research programme between Zeneca Pharmaceuticals and the Institute of Cancer Research (UK...
-
Article
Endocrine, pharmacokinetic and clinical studies of the aromatase inhibitor 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione ('pyridoglutethimide') in postmenopausal breast cancer patients
The aromatase inhibitor, 'pyridoglutethimide' (PyG), has been shown previously to suppress serum oestrogen levels in postmenopausal breast cancer patients and to achieve clinical responses at a dose of 500 mg ...
-
Article
The influence of CGS 16949A on peripheral aromatisation in breast cancer patients
The influence of a new aromatase inhibitor, CGS 16949A on peripheral aromatisation of androstenedione into oestrone was investigated in postmenopausal women with breast cancer. A mixture of 3H androstenedione ...
-
Article
Radiotherapy for stage I Hodgkin's disease: 20 years experience at St Bartholomew's Hospital
One hundred and one consecutive patients with newly diagnosed stage I Hodgkin's disease (HD) received treatment at St Bartholomew's Hospital, between 1968 and 1987, with a median follow-up of 12 years. Eleven ...
-
Article
Activation of murine 'T' lymphomas in the presence of a human myeloma cell line, RPMI-8226, in vivo
-
Article
Tumour necrosis factor in man: Clinical and biological observations
Eighteen patients with advanced cancer have been treated intravenously with human recombinant tumour necrosis factor (rhTNF). The drug produced febrile reactions at all doses although these were preventable by...
-
Article
Experimental Production of Interstitial Cell Tumours